These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36980066)

  • 1. The Effect of SSRI Exposure in Pregnancy on Early Respiratory and Metabolic Adaptation in Infants Born Preterm.
    Gover A; Endrawes K; Molad M; Lavie-Nevo K; Riskin A
    Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.
    Hogue AN; Temple-Cooper ME; Lagzdins M; Worley S; Scwersenski J; Floyd R; Saker F
    J Neonatal Perinatal Med; 2017; 10(4):371-380. PubMed ID: 29286926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
    Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
    Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC; Saccone G; Berghella V
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Delivery Room Resuscitation of Neonates Exposed to Selective Serotonin Reuptake Inhibitors.
    Ulbrich KA; Zumpf K; Ciolino JD; Shah M; Miller ES; Wisner KL
    J Pediatr; 2021 May; 232():103-108.e2. PubMed ID: 33453205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.
    Forsberg L; Navér L; Gustafsson LL; Wide K
    PLoS One; 2014; 9(11):e111327. PubMed ID: 25365553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure.
    Oberlander TF; Grunau R; Mayes L; Riggs W; Rurak D; Papsdorf M; Misri S; Weinberg J
    Early Hum Dev; 2008 Oct; 84(10):689-97. PubMed ID: 18639992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
    Laine K; Heikkinen T; Ekblad U; Kero P
    Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS
    J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927
    [No Abstract]   [Full Text] [Related]  

  • 14. A Prospective Study Evaluating the Effects of SSRI Exposure on Cardiac Size and Function in Newborns.
    Ansah DA; Reinking BE; Colaizy TT; Roghair RD; Haskell SE
    Neonatology; 2019; 115(4):320-327. PubMed ID: 30836356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure.
    Corti S; Pileri P; Mazzocco MI; Mandò C; Moscatiello AF; Cattaneo D; Cheli S; Baldelli S; Pogliani L; Clementi E; Cetin I
    Front Pediatr; 2019; 7():309. PubMed ID: 31403037
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density.
    Dubnov-Raz G; Hemilä H; Vurembrand Y; Kuint J; Maayan-Metzger A
    Early Hum Dev; 2012 Mar; 88(3):191-4. PubMed ID: 21890289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study.
    de Vries NK; van der Veere CN; Reijneveld SA; Bos AF
    PLoS One; 2013; 8(5):e64654. PubMed ID: 23785389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phototherapy-mediated syndrome of inappropriate secretion of antidiuretic hormone in an in utero selective serotonin reuptake inhibitor-exposed newborn infant.
    Vanhaesebrouck P; De Bock F; Zecic A; De Praeter C; Smets K; De Coen K; Goossens L
    Pediatrics; 2005 May; 115(5):e508-11. PubMed ID: 15805337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
    Lund N; Pedersen LH; Henriksen TB
    Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.